To determine whether inflammation contributes to Alzheimer's disease rather than being merely a correlative pathological feature in the AD brain, we and others tested the hypothesis that ACT and/or apoE serve as amyloid catalysts or pathological chaperones. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.